BCM
ASXC

Bluefin Capital Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Bluefin Capital Management’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-80,100
Closed -$2K – 1032
2021
Q4 		$2K Hold
80,100
– – ﹤0.01% 875
2021
Q3 		$10K Hold
80,100
– – ﹤0.01% 664
2021
Q2 		$76K Sell
80,100
-443,200
-85% -$1.11M ﹤0.01% 484
2021
Q1 		$435K Buy
+523,300
New +$1.9M 0.02% 321

Other funds holding ASXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bluefin Capital Management's ASXC Position: Q3 2021 in Review

Bluefin Capital Management sold out of Asensus Surgical, Inc. (ASXC) in Q3 2021, closing a stake of 109,204 shares — an estimated $245K sold.

Bluefin Capital Management first reported a position in ASXC in Q2 2021 and held it in 1 quarter. The position peaked at $346K in Q2 2021. 111 funds tracked by Wall St. Rank hold ASXC as of Q3 2021.

  • Bluefin Capital Management reported no remaining Asensus Surgical, Inc. position as of Q3 2021 after selling out during the quarter.
  • Bluefin Capital Management sold 109,204 Asensus Surgical, Inc. shares in Q3 2021, an estimated $245K.
  • Bluefin Capital Management first reported a position in Asensus Surgical, Inc. in Q2 2021 and held it in 1 quarter.
  • Bluefin Capital Management's Asensus Surgical, Inc. position peaked at $346K in Q2 2021.
  • 111 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2021.

Based on Bluefin Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.